At the end of each week, the law firm d’Oliveira & Associates compiles a summary of recalls, FDA warnings, market withdrawals and safety alerts that the public should be aware of for their …
GLENDALE HEIGHTS, Ill. (BUSINESS WIRE) Medefil, Inc., a domestic manufacturer of injectable products, has announced availability of its FDA-approved ANDA products, Atropine Sulfate Injection, USP, 1 mg per 10 mL (0.1 mg/mL), and 10% Calcium Chloride Injection, USP, 1000 mg per 10 mL (100 mg/mL). Both are offered i.
/PRNewswire/ American Regent, Inc. has announced the launch of Atropine Sulfate Injection, USP, a longstanding injectable medication, now with FDA approval..